The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of  3 H-norepinephrine released from the adrenergic neuron.
D018663:Adrenergic Agents / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D006321:Heart / Q000294:innervation; D066298:In Vitro Techniques; D008297:Male; D008680:Metaraminol / Q000494:pharmacology*; D008745:Methylation; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000032:analysis; D010477:Perfusion; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000378:metabolism; D014191:Tranylcypromine / Q000494:pharmacology; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology*
D018663:Adrenergic Agents; D001555:Benzene Derivatives; D006146:Guanidines; D008996:Monoamine Oxidase Inhibitors; D011807:Quinolizines; D009647:Normetanephrine; D014316:Tritium; D014191:Tranylcypromine; D008680:Metaraminol; D000661:Amphetamine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine